Protamine sulfate
Protamine sulfate is an antidote used intravenously to neutralise the anticoagulant effect of heparin, for example to reverse heparinisation after cardiopulmonary bypass or to treat heparin overdose.
Adult dose
Dose auto-extracted from US FDA prescribing information (openFDA / DailyMed) — cross-check; US labelling may differ from UK — not yet clinician-verified. Always confirm against the product SmPC and your local formulary before prescribing.
Contraindications
- Previous intolerance to the drug
Side effects
- Sudden fall in blood pressure and bradycardia (with IV administration)
- Transitory flushing and feeling of warmth
- Dyspnoea, nausea, vomiting and lassitude
- Back pain (reported in conscious patients undergoing procedures such as cardiac catheterisation)
- Severe: anaphylaxis / anaphylactoid reactions with circulatory collapse, capillary leak and non-cardiogenic pulmonary oedema; acute pulmonary hypertension
Interactions
- Physically incompatible with certain antibiotics, including several cephalosporins and penicillins — do not mix without knowledge of compatibility
Clinical monograph
How it works
Being strongly basic, protamine binds tightly to acidic heparin to form an inactive stable complex, thereby reversing heparin-induced anticoagulation; it also has partial activity against low molecular weight heparins.
Prescribing in practice
- Rapid intravenous injection can cause severe hypotension, bradycardia and anaphylactoid or pulmonary hypertensive reactions, so administer slowly with facilities for resuscitation available.
- Excess protamine relative to circulating heparin can itself have an anticoagulant effect, so the dose must be titrated to the amount of heparin to be neutralised.
- The risk of serious hypersensitivity is increased in patients exposed to protamine-containing insulins, those with fish allergy and previously vasectomised or infertile men.
Monitoring
Monitor blood pressure, heart rate and clotting (such as activated clotting time or APTT) during and after administration to confirm reversal and guide dosing.
Counselling the patient
- Explain to the team that protamine is being given to reverse heparin and that blood pressure and heart rate are being watched for reactions.
- Note any history of fish allergy or previous protamine or protamine-insulin exposure before administration.
Evidence & guidelines
Protamine is the established agent for reversing heparin anticoagulation, with only partial neutralisation of low molecular weight heparins and minimal effect on fondaparinux.
Reference: AAGBI; UK guidelines; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. The structured dose values shown have been reviewed by a clinician. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Difficult Airway Algorithm (DAS) · DAS 2015; Royal College of Anaesthetists
- Major Haemorrhage Protocol · NICE NG24; UK MHP guidelines
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Featured in these MRCEM clinical pathways
Protamine sulfate is a core drug in the following exam-focused workups on our sister siteReviseMRCEM.
MRCEM Primary / Intermediate / OSCE candidates: each pathway includes exam-style questions, RCEM/NICE citations, and FAQ summaries.